The first COVID-19 vaccines were administered to Philadelphians on Wednesday morning.
Jefferson University Hospital on 11th Street in Center City was among the few hospitals here to receive doses of the vaccine manufactured by Pfizer and BioNTech. The first doses at Jefferson were given at 7:30 a.m.
âItâs precious. Itâs like liquid gold,â said Dr. Sandra E. Brooks, a chief medical officer for the Jeffersonâs Center City division, about the vaccine.
Around 10:30 a.m. Brooks stood inside the hospitalâs Anthony F. DePalma Auditorium, where two of the hospital s four vaccine stations were set up. Sixteen vaccines were given every hour.
The COVID-19 vaccine wasn t tested in pregnancy, but experts say it s still worth considering if you re expecting inquirer.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from inquirer.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
NETANYA, Israel, Dec. 14, 2020 /PRNewswire/ Theranica, a prescribed digital therapeutics company developing advanced electroceuticals for migraine and other pain conditions, announced today that a new peer-reviewed systemic review and meta-analysis of randomized controlled trials found that remote electrical neuromodulation (REN) was the only neuromodulation-based acute migraine treatment with sufficient clinical evidence to conclude that it is effective. As non-invasive neuromodulation is an emerging field in the treatment of migraine, an unbiased systemic review was important to understand what may really be benefitting patients, said Prof. Stephen Silberstein, MD, director of the Headache Center at the Jefferson University Hospital in Philadelphia. While the industry should conduct more studies to understand the potential of neuromodulation for migraine treatment, this study certainly helps comparing between the different emerging t